A recent study showed that apigenin treatment prevents cognitive deficits and recovers behavioral impairments without changing seizure severity in kindled mice, which can be attributed to CREB–BDNF upregulation in the hippocampus [78]. The gene discussed is CREB1; the disease is Cognitive impairment.